Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Human RGM249-derived small RNAs potentially regulate tumor malignancy.

Miura N, Shimizu M, Shinoda W, Tsuno S, Sato R, Wang X, Jo J, Tabata Y, Hasegawa J.

Nucleic Acid Ther. 2013 Oct;23(5):332-43. doi: 10.1089/nat.2013.0424.

2.

Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma.

Bergé M, Bonnin P, Sulpice E, Vilar J, Allanic D, Silvestre JS, Lévy BI, Tucker GC, Tobelem G, Merkulova-Rainon T.

Am J Pathol. 2010 Dec;177(6):3192-201. doi: 10.2353/ajpath.2010.100157. Epub 2010 Oct 22.

3.

Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.

Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE.

Ann Surg. 2004 Oct;240(4):667-74; discussion 675-6.

4.

Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.

Zhao X, Zhu DM, Gan WJ, Li Z, Zhang JL, Zhao H, Zhou J, Li DC.

Oncol Rep. 2013 Mar;29(3):1019-26. doi: 10.3892/or.2012.2203. Epub 2012 Dec 19.

PMID:
23254994
5.

[Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].

Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL.

Ai Zheng. 2004 Jun;23(6):619-25. Chinese.

PMID:
15191658
6.

RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.

Park MY, Park YS, Nam JH.

Int J Oncol. 2011 Oct;39(4):853-61. doi: 10.3892/ijo.2011.1095. Epub 2011 Jun 22.

PMID:
21701774
7.

Vitronectin silencing inhibits hepatocellular carcinoma in vitro and in vivo.

Zhu W, Li W, Yang G, Fu C, Jiang G, Hu Q.

Future Oncol. 2015;11(2):251-8. doi: 10.2217/fon.14.202. Epub 2014 Sep 2.

PMID:
25179307
8.

[RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1].

Xu WJ, Zhang S, Zhang N, Yang Y, Wei YQ, Deng HX.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;42(4):455-60. Chinese.

PMID:
21866625
9.

A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.

Chen X, Lin J, Kanekura T, Su J, Lin W, Xie H, Wu Y, Li J, Chen M, Chang J.

Cancer Res. 2006 Dec 1;66(23):11323-30.

10.

Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studies.

Zhang YW, Niu J, Lu X, Yang YX, Zhao HW, He X, Yin GW, Wu JD, Yan DL, Sun JF, Wen JF, Feng JF, Xue HZ, Lau WY.

J Hepatol. 2013 Mar;58(3):502-8. doi: 10.1016/j.jhep.2012.11.002. Epub 2012 Nov 10.

PMID:
23149065
11.

Interfering growth of malignant melanoma with Ang2-siRNA.

Wang B, Liu Z, Zhang M, San X, Zhang Y, Zhang W, Wang M.

Mol Biol Rep. 2013 Feb;40(2):1463-71. doi: 10.1007/s11033-012-2189-4. Epub 2012 Nov 16.

12.

[Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].

Xu JY, Chen LB, Xu JY, Yang Z, Xu RH, Wei HY.

Zhonghua Wai Ke Za Zhi. 2006 Apr 1;44(7):481-4. Chinese.

PMID:
16772086
13.

An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.

Wu C, Gong F, Pang P, Shen M, Zhu K, Cheng D, Liu Z, Shan H.

PLoS One. 2013 Jun 7;8(6):e66416. doi: 10.1371/journal.pone.0066416. Print 2013.

14.

Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.

Xiong Z, Lü MH, Fan YH, Cao YL, Hu CJ, Wu YY, Wang SM, Luo G, Fang DC, Li C, Yang SM.

Int J Oncol. 2012 May;40(5):1601-9. doi: 10.3892/ijo.2012.1338. Epub 2012 Jan 20.

PMID:
22267022
15.

Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.

Han L, Tang C, Yin C.

Biomaterials. 2014 May;35(15):4589-600. doi: 10.1016/j.biomaterials.2014.02.027. Epub 2014 Mar 6.

PMID:
24613049
16.

Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma.

Matsumoto G, Kushibiki T, Kinoshita Y, Lee U, Omi Y, Kubota E, Tabata Y.

Cancer Sci. 2006 Apr;97(4):313-21.

17.

[Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].

Hu H, Ran YL, Yu L, Zhou Z, Lou JN, Yang ZH.

Ai Zheng. 2007 May;26(5):453-7. Chinese.

PMID:
17672931
18.

Silencing cathepsin S gene expression inhibits growth, invasion and angiogenesis of human hepatocellular carcinoma in vitro.

Fan Q, Wang X, Zhang H, Li C, Fan J, Xu J.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):703-10. doi: 10.1016/j.bbrc.2012.07.013. Epub 2012 Jul 13.

PMID:
22796222
19.

Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.

Yang WL, Wei L, Huang WQ, Li R, Shen WY, Liu JY, Xu JM, Li B, Qin Y.

Oncol Rep. 2014 May;31(5):2328-34. doi: 10.3892/or.2014.3111. Epub 2014 Mar 24.

PMID:
24676454
20.

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.

Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.

PMID:
22979990

Supplemental Content

Support Center